Start with a decision map rather than a single launch date. Identify the medicinal product, the available dossier, the target indication and the intended Swiss customer channels. An existing foreign approval is an input to route selection, not a substitute for checking the Swiss pathway. Mark assumptions explicitly so that the project team knows which dates depend on unresolved regulatory or commercial decisions.
Questions to resolve with your Swiss partner
Organise the work into parallel streams: authorisation, local responsibilities, reimbursement, supply and commercial execution. Give each stream an accountable owner and a concrete next decision. Keep authority milestones distinct from your own readiness milestones. A product may be authorised while packaging, supply, price discussions or local operating arrangements still need work.
- Record the existing approvals and the available dossier version.
- Define the target indication, customers and proposed operating model.
- Map dependencies between authorisation, reimbursement and supply.
- Agree decision owners and a date for reviewing unresolved assumptions.
This independent resource helps pharmaceutical businesses prepare questions for appropriately qualified providers. It is not a regulator, licence holder or substitute for product-specific regulatory advice. Official publications and the applicable legislation take precedence. No authorisation outcome, provider availability, fee or completion date is guaranteed.
Readiness checklist →